Medical

This audio file contains all 7 interviews on this edition.

• Track 1, The importance of residual cognitive symptoms of major depressive disorder
• Track 2, The treatment of schizophrenia – thinking long term from the beginning
• Track 3, What’s new with vaccines in 2018?
• Track 4, Invasive Meningococcal Disease in Australia: The importance of serogroup B
• Track 5, Individualising therapy for the patient in front of you – Case studies in type 2 diabetes
• Track 6, The NEW Medicare items for retinal photography for patients with type 2 diabetes
• Track 7, Considerations when prescribing testosterone replacement therapy?

To view reference lists or product information please go to the individual tracks.

Just one fracture can be devastating to a patient, especially if the first fracture is a hip fracture. In Australia 66% of adults over 50 have either osteoporosis or osteopenia, so we discuss screening, the new MBS codes, risk profiles and more in this interview. 

Menopause hormone therapy (MHT) remains the gold standard for treating vasomotor symptoms among the symptomatic peri- and early postmenopausal women. Prescribing MHT is in the domain of the GP, so this interview is a practical tutorial, to assist GPs in providing symptom relief around menopause.

Due to the restrictive inclusion and exclusion criteria, only about 5% of patients with asthma are represented in randomised clinical trials. Real world data facilitates the transition from science into the clinic, so in this interview we discuss the Salford Lung Study with Dave Leather.

When antidepressant therapy is needed, it’s important to consider both efficacy (response rate) and acceptability (treatment discontinuations due to any cause). A recent systematic review and network meta-analysis, published in THE LANCET did just this, so we discuss some of the findings.

All people with diabetes are at risk of developing retinopathy (DR), but early detection and treatment may prevent up to 98% of severe vision loss. This interview discusses screening and recall systems to prevent patients falling through the gaps….

A short product update on an alternative to typical opioids for patients with moderate to severe pain.

This audio file contains all 6 interviews on this edition.

• Track 1, Osteoporosis – Find them early, prevent the fracture
• Track 2, Let’s get practical with menopause hormone therapy
• Track 3, Asthma – Bridging the gap between pure science and the real world
• Track 4, Depression, weight, and sexual function
• Track 5, Type 2 diabetes – Diabetic retinopathy is potentially avoidable
• Track 6, Alternatives to typical opioids

To view reference lists or product information please go to the individual tracks.

Identifying symptoms of depression and patient willingness to start treatment are key challenges to effective treatment. Patient preference, as well as the features of the episode are important considerations, so we talk to both a patient and David Hogan about patient-centred care for depression.

Medical jargon can be confusing for patients, so we discuss a useful resource that helps to take away the confusion. Through illustrated flip-through stories, patients can learn about depression, symptoms, treatments, support groups and the emotional roller coaster that comes with living with depression.